Derrick A. Mensah
Kumasi, AH, Ghana
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Assessing the efficacy of high-dose rifampicin plus albendazole against onchocerciasis.
Journal: PLoS neglected tropical diseases
Published: March 01, 2026
High-Dose Rifampicin Plus Albendazole Rapidly Clears Lymphatic Filariasis Circulating Filarial Antigen in a Randomised Clinical Trial: A Promising Step Toward Short-Course Macrofilaricidal Therapy.
Journal: Pathogens (Basel, Switzerland)
Published: January 04, 2026
Humoral immune response to COVID-19 vaccines in onchocerciasis-infected individuals: a field study from Ghana.
Journal: Frontiers in immunology
Published: May 22, 2025
Helminth Seropositivity Inversely Correlated with Th1 and Th17 Cytokines and Severe COVID-19.
Journal: Vaccines
Published: December 23, 2024
Changes in circulating filarial antigen status in previously positive individuals: Lessons for treatment monitoring and pre-transmission assessment surveys.
Journal: PLoS neglected tropical diseases
Published: June 02, 2024
Adherence to Hygiene Protocols and Doxycycline Therapy in Ameliorating Lymphatic Filariasis Morbidity in an Endemic Area Post-Interruption of Disease Transmission in Ghana.
Journal: The American journal of tropical medicine and hygiene
Published: May 10, 2024
Association of haemato-biochemical indices and blood composite ratios with microfilaridermia in Onchocerciasis patients.
Journal: BMC infectious diseases
Published: November 03, 2023
First genome-wide association study for lymphatic filariasis in a West African population points to a human leukocyte antigen-mediated disease pathophysiology.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: February 22, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026